Title | An Open-Label, Randomized Phase 3 Study to Evaluate Enfortumab Vedotin vs Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301) |
---|---|
Disease/Condition | Bladder Cancer,Metastatic Cancer,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Urologic Diseases,Geriatrics,Neoplasms,Urogenital Neoplasms |
Description | |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Benjamin Gartrell, MD |
Contact Name | Gina Aracena |
Contact Email | gihernan@montefiore.org |
Protocol Number | 18-06-129-01 |
Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
Status | Active/Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Sub-Specialty | Medical and Hematologic Oncology - Bladder |
Adult, Pediatric, Both | Adult |